What are you looking for?
Complement inhibitors are emerging as a potential treatment option for geographic atrophy (GA). Paired with artificial intelligence (AI), these medicines will play an increasing role in managing individuals with GA. We asked a vitreoretinal expert Mitul Mehta, MD, MS, FASRS, Clinical Associate Professor of Ophthalmology at the Gavin Herbert Eye Institute, University of California, Irvine... ...
Voice Over: Ophthalmology 360 presents Amy Dixon: Paralympian, advocate, mentor, and speaker. Introduction Amy Dixon: My name is Amy Dixon. I am...
While genetic testing is on the rise – and showing promise for patient selection – innovative treatment options are lagging. But some...
A retinal specialist said she believes the day is coming soon. For now, follow these best practices. Age-related macular degeneration...
Welcome to the Ophthalmic Project—a series of blogs and podcasts written and produced by Mark L. Dlugoss, senior contributing editor. The Ophthalmic Project will address trends, events, and observations in... ...
By Elizabeth Yeu, MD We cannot see what we are not looking for. Before I began purposefully looking for signs of Demodex during my slit-lamp exams, I thought the prevalence...
By Mark L. Dlugoss Senior Contributing Editor For ophthalmologists, vision clinicians, and researchers, the year 2020 was slated as a special year—“The Year of the Eye.” Over the last 25...
Presentation A 78-year-old woman with a history of diabetes and hypertension presented complaining of significant ocular surface symptoms: burning, irritation, and foreign body sensation, but primarily tearing. Prior treatment included...
By Merin Abraham, OD Several novel modes of treatment are now available to eye care providers to treat glaucoma, although topical medications remain the most common modality. A major determinant...